Disease-modifying peripheral neuropathy treatments — targeting the underlying pathological mechanisms causing nerve damage rather than merely suppressing neuropathic pain symptoms — represent the emerging therapeutic frontier, with the Peripheral Neuropathy Market reflecting the growing investment in disease modification as the unmet need that symptomatic treatments inadequately...